Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; v3.0.1 is removed, and the Back to Top link is deleted. No observable changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T23:23:49.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:11:02.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several medical terms and location details have been removed.
    Difference
    1%
    Check dated 2025-08-31T12:53:21.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-08-24T09:20:14.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and a revision change, indicating a recent update to the content.
    Difference
    0.5%
    Check dated 2025-08-17T05:15:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:53:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.